B. Riley Financial, Inc. Abb Vie Inc. Transaction History

B. Riley Financial, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $399,739 - $444,384	-4,496 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $68,951 - $81,584	-768 Reduced 14.59%	4,496 $439,000
Q1 2018 May 04, 2018	SELL	$92.01 - $123.21 $32,571 - $43,616	-354 Reduced 6.3%	5,264 $499,000
Q4 2017 Feb 09, 2018	BUY	$89.56 - $98.21 $26,151 - $28,677	292 Added 5.48%	5,618 $544,000
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $372,021 - $475,185	5,326	5,326 $473,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of B. Riley Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on B. Riley Financial, Inc. with notifications on news.